An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial ...
An asthma drug has shown positive results when used to treat nasal polyps, researchers have said. Tezepelumab was first ...
Positive results from the Tezspire phase III WAYPOINT trial highlight rapid and sustained effect in chronic rhinosinusitis with nasal polyps: Cambridge, UK Tuesday, March 4, 2025, ...
US FDA accepts for review GSK’s BLA for depemokimab for asthma with type 2 inflammation and for chronic rhinosinusitis with nasal polyps: London, UK Tuesday, March 4, 2025, 09:0 ...
The Institute for Clinical and Economic Review (ICER) released a report on Monday assessing the clinical effectiveness and ...
London: GSK plc has announced the US Food and Drug Administration (FDA) has accepted for review the Biologics License ...
To promote nose breathing while sleeping, your partner can try applying nasal strips or clearing the sinuses with a nasal ...
Among patients with chronic rhinosinusitis, higher IL-6 and IL-8 levels had links to decreases in several cognitive function ...